Abstract:Antibiotic resistance has become a major public health concern as bacteria evolve to evade drugs, leading to recurring infections and a decrease in antibiotic efficacy. Systematic efforts have revealed mechanisms involved in resistance. Yet, in many cases, how these specific mechanisms accelerate or slow the evolution of resistance remains unclear. Here, we conducted a systematic study of the impact of the AcrAB-TolC efflux pump on the evolution of antibiotic resistance. We mapped how population growth rate and resistance change over time as a function of both the antibiotic concentration and the parent strain's genetic background. We compared the wild-type strain to a strain overexpressing AcrAB-TolC pumps and a strain lacking functional pumps. In all cases, resistance emerged when cultures were treated with chloramphenicol concentrations near the MIC of their respective parent strain. The genetic background of the parent strain also influenced resistance acquisition. The wild-type strain evolved resistance within 24 h through mutations in the acrAB operon and its associated regulators. Meanwhile, the strain overexpressing AcrAB-TolC evolved resistance more slowly than the wild-type strain; this strain achieved resistance in part through point mutations in acrB and the acrAB promoter. Surprisingly, the strain without functional AcrAB-TolC efflux pumps still gained resistance, which it achieved through upregulation of redundant efflux pumps. Overall, our results suggest that treatment conditions just above the MIC pose the largest risk for the evolution of resistance and that AcrAB-TolC efflux pumps impact the pathway by which chloramphenicol resistance is achieved.IMPORTANCE Combatting the rise of antibiotic resistance is a significant challenge. Efflux pumps are an important contributor to drug resistance; they exist across many cell types and can export numerous classes of antibiotics. Cells can regulate pump expression to maintain low intracellular drug concentrations. Here, we explored how resistance emerged depending on the antibiotic concentration, as well as the presence of efflux pumps and their regulators. We found that treatments near antibiotic concentrations that inhibit the parent strain's growth were most likely to promote resistance. While wild-type, pump overexpression, and pump knockout strains were all able to evolve resistance, they differed in the absolute level of resistance evolved, the speed at which they achieved resistance, and the genetic pathways involved. These results indicate that specific treatment regimens may be especially problematic for the evolution of resistance and that the strain background can influence how resistance is achieved.

Heterogeneity in efflux pump expression predisposes antibiotic-resistant cells to mutation

The crosstalk between efflux pump and resistance gene mutation in Helicobacter pylori

Mapping the Role of AcrAB-TolC Efflux Pumps in the Evolution of Antibiotic Resistance Reveals Near-MIC Treatments Facilitate Resistance Acquisition

Three concurrent mechanisms generate gene copy number variation and transient antibiotic heteroresistance

An A666G mutation in transmembrane helix 5 of the yeast multidrug transporter Pdr5 increases drug efflux by enhancing cooperativity between transport sites

Heterogeneous efflux pump expression underpins phenotypic resistance to antimicrobial peptides

Identification of essential genes that support fitness of efflux pump overproducers in the presence of fluoroquinolone

Common regulatory mutation increases single-cell survival to antibiotic exposures in .

Bacterial heterozygosity promotes survival under multidrug selection

Mutations in the efflux regulator gene oqxR provide a simple genetic switch for antimicrobial resistance in Klebsiella pneumoniae

Nonoptimal Gene Expression Creates Latent Potential for Antibiotic Resistance

Efflux pumps and membrane permeability contribute to intrinsic antibiotic resistance in

Mutations causing low level antibiotic resistance ensure bacterial survival in antibiotic-treated hosts

Phenotypic heterogeneity in bacteria: the rise of antibiotic persistence, clinical implications, and therapeutic opportunities

Antibiotic resistant bacteria survive treatment by doubling while shrinking

Efflux pumps mediate changes to fundamental bacterial physiology via membrane potential

Identification of Determinants that Allow Maintenance of High-Level Fluoroquinolone Resistance in

ppGpp and RNA-polymerase backtracking guide antibiotic-induced mutable gambler cells

Antibiotic Treatment Enhances the Genome-Wide Mutation Rate of Target Cells.

Membrane permeability and regulation of drug "influx and efflux" in enterobacterial pathogens

Dynamic Boolean modelling reveals the influence of energy supply on bacterial efflux pump expression